Drawing for CAREMETX

USPTO serial 90735257

CAREMETX

Reviewed by CopyMark Law Group

Reg. 6945695Status 700Registered
Filing date
Status date
Registration date
Jan 10, 2023
Examiner
NEAL, KELLY L
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CAREMETX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nancy S. Lapidus

Nancy S. Lapidus THE LAW OFFICE OF NANCY LAPIDUS, PLLC5335 WISCONSIN AVENUE, N.W.SUITE 440WASHINGTON, DC 20015

Goods and services

ClassDescriptionStatusFirst use
035Providing medical and prescription benefit and support services to patients, providers, and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies, namely, non-clinical data and information related to access, affordability, and adherence for drugs, devices, pharmaceuticals, medicines, biologics, and therapies; business services provided to manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies, namely, collecting, organizing, categorizing, managing, interpreting, analyzing, storing, aggregating, de-identifying, and reporting of health care information, patient data, health care quality and cost data, and coverage and benefit data for business purposes; and providing electronic business services to manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies, namely, collecting, organizing, categorizing, managing, interpreting, analyzing, storing, aggregating, de-identifying, and reporting of health care information, patient data, health care quality and cost data, and coverage and benefit data for business purposesACTIVE—
036Providing warranties on goods manufactured by others, namely, drugs, devices, pharmaceuticals, medicines, biologics, and therapies; administration of health care reinsurance programs, claims, and processing; reinsurance services, namely, underwriting, reinsurance premium rate computing, and administering health care reinsurance programs; development of health care reinsurance programs and agreements; and health care reinsurance services, namely, reinsurance intermediary management services in the field of drugs, devices, pharmaceuticals, medicines, biologics, and therapiesACTIVE—
042Software as a service (SaaS) services featuring software for medical and prescription benefit and support services to patients, providers, and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies; providing online non-downloadable software for accessing, initiating, viewing, managing, and analyzing medical and prescription benefit and support services for patients, providers, and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies; software as a service (SaaS) services featuring software for advising and providing information to patients, providers, and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies in the fields of health care, medical and prescription insurance benefits, medical and prescription insurance coverage, financial programs, cost management, and payment options; providing online non-downloadable software for advising and providing information to patients, providers, and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies in the fields of health care, medical and prescription insurance benefits, medical and prescription insurance coverage, financial programs, cost management, and payment options; software as a service (SaaS) services featuring software for patient support services for health and medical case management; providing online non-downloadable software for accessing patient support services for health and medical case management; software as a service (SaaS) services featuring software for business services provided to manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies, namely, collecting, organizing, categorizing, managing, interpreting, analyzing, storing, aggregating, de-identifying, and reporting of health care information, patient data, health care quality and cost data, and coverage and benefit data for business purposes; providing online non-downloadable software for business services provided to manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies, namely, collecting, organizing, categorizing, managing, interpreting, analyzing, storing, aggregating, de-identifying, and reporting of health care information, patient data, health care quality and cost data, and coverage and benefit data for business purposes; software as a service (SaaS) services featuring software for medical and prescription benefit and patient support hub services, namely, determining and communicating medical and prescription benefit information, determining and communicating medical and prescription benefit and insurance coverage and reimbursement investigation and verification, obtaining patient authorization and consent and physician attestation with respect to performance of services and disclosure of information, providing prior authorization support, claims and appeals support, payer policy research, prescription access and delivery administration and support, copay support, eligibility determination, and enrollment, financial assistance, patient assistance, and free drug program support, eligibility determination, and enrollment, and patient education and support, all for patients, providers, pharmacies, and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies; providing online non-downloadable software for medical and prescription benefit and patient support hub services, namely, determining and communicating medical and prescription benefit information, determining and communicating medical and prescription benefit and insurance coverage and reimbursement investigation and verification, obtaining patient authorization and consent and physician attestation with respect to performance of services and disclosure of information, providing prior authorization support, claims and appeals support, payer policy research, prescription access and delivery administration and support, copay support, eligibility determination, and enrollment, financial assistance, patient assistance, and free drug program support, eligibility determination, and enrollment, and patient education and support, all for patients, providers, pharmacies, and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies; software as a service (SaaS) services featuring software for customer relationship management; providing online non-downloadable software for customer relationship management; providing application programming interfaces featuring application programming interface (API) software for enabling users, partners, vendors, patients, providers and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies to access and interact with software applications for providing medical and prescription benefit and support services; providing application programming interfaces featuring application programming interface (API) software for enabling users, partners, vendors, patients, providers and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies to access and interact with software applications for advising and providing information in the fields of health care, medical and prescription insurance benefits, medical and prescription insurance coverage, financial programs, cost management, and payment options; providing application programming interfaces featuring application programming interface (API) software for enabling users, partners, vendors, patients, providers and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies to access and interact with software applications for providing patient support services for health and medical case management; providing application programming interfaces featuring application programming interface (API) software for enabling users, partners, vendors, patients, providers and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies to access and interact with software applications for providing business services, namely, collecting, organizing, categorizing, managing, interpreting, analyzing, storing, aggregating, de-identifying, and reporting of health care information, patient data, health care quality and cost data, and coverage and benefit data for business purposes; providing application programming interfaces featuring application programming interface (API) software for enabling users, partners, vendors, patients, providers and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies to access and interact with software applications for providing medical and prescription benefit and patient support hub services, namely, determining and communicating medical and prescription benefit information, determining and communicating medical and prescription benefit and insurance coverage and reimbursement investigation and verification, obtaining patient authorization and consent and physician attestation with respect to performance of services and disclosure of information, providing prior authorization support, claims and appeals support, payer policy research, prescription access and delivery administration and support, copay support, eligibility determination, and enrollment, financial assistance, patient assistance, and free drug program support, eligibility determination, and enrollment, and patient education and support, all for patients, providers, pharmacies, and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies; medical and prescription benefit and patient support hub services, namely, providing a website featuring technology allowing users to determine and communicate medical and prescription benefit information, determine and communicate medical and prescription benefit and insurance coverage and reimbursement investigation and verification, obtain patient authorization and consent and physician attestation with respect to performance of services and disclosure of information, provide prior authorization support, claims and appeals support, payer policy research, prescription access and delivery administration and support, copay support, eligibility determination, and enrollment, financial assistance, patient assistance, and free drug program support, eligibility determination, and enrollment, and patient education and support, all for patients, providers, pharmacies, and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies; and electronic medical and prescription benefit and patient support hub services, namely, providing a website featuring technology that allows users to determine and communicate medical and prescription benefit information, determine and communicate medical and prescription benefit and insurance coverage and reimbursement investigation and verification, obtain patient authorization and consent and physician attestation with respect to performance of services and disclosure of information, provide prior authorization support, claims and appeals support, payer policy research, prescription access and delivery administration and support, copay support, eligibility determination, and enrollment, financial assistance, patient assistance, and free drug program support, eligibility determination, and enrollment, and patient education and support, all for patients, providers, pharmacies, and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapiesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 10, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 10, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 25, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 25, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 5, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 19, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 2, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 2, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 2, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 30, 2022DOCKASSIGNED TO EXAMINER—
Mar 4, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 4, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 4, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 8, 2022DOCKASSIGNED TO EXAMINER—
Aug 20, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 29, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance